Publicaciones (14) Publicaciones de MARÍA NÚÑEZ NÚÑEZ

2024

  1. Post-publication research integrity concerns in randomized clinical trials: A scoping review of the literature

    International Journal of Gynecology and Obstetrics

2023

  1. Assessing the Integrity of Clinical Trials Included in Evidence Syntheses

    International Journal of Environmental Research and Public Health, Vol. 20, Núm. 12

  2. Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety

    Frontiers in Pharmacology, Vol. 14

  3. International multi-stakeholder consensus statement on clinical trial integrity

    BJOG: An International Journal of Obstetrics and Gynaecology, Vol. 130, Núm. 9, pp. 1096-1111

  4. Research integrity in randomized clinical trials: A scoping umbrella review

    International Journal of Gynecology and Obstetrics, Vol. 162, Núm. 3, pp. 860-876

2022

  1. Compatibility of prolonged infusion antibiotics during Y-site administration

    Nursing in Critical Care, Vol. 27, Núm. 6, pp. 849-858

  2. Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19

    Frontiers in Immunology, Vol. 13

  3. Predictors of inappropriate antimicrobial prescription: Eight-year point prevalence surveys experience in a third level hospital in Spain

    Frontiers in Pharmacology, Vol. 13

  4. Research integrity in clinical trials: innocent errors and spin versus scientific misconduct

    Current Opinion in Obstetrics and Gynecology, Vol. 34, Núm. 5, pp. 332-339

  5. Second Victim Support at the Core of Severe Adverse Event Investigation

    International journal of environmental research and public health, Vol. 19, Núm. 24

2021

  1. Glucocorticoids alone versus tocilizumab alone or glucocorticoids plus tocilizumab in patients with severe SARS-CoV-2 pneumonia and mild inflammation

    Medicina Clinica, Vol. 156, Núm. 12, pp. 602-605

2020

  1. Dalbavancin is a novel antimicrobial against Gram-positive pathogens: Clinical experience beyond labelled indications

    European Journal of Hospital Pharmacy, Vol. 27, Núm. 5, pp. 310-312

  2. Randomized, double-blind, controlled trial, phase III, to evaluate the use of platelet-rich plasma versus hyaluronic acid in hip coxarthrosis

    Revista Espanola de Cirugia Ortopedica y Traumatologia, Vol. 64, Núm. 2, pp. 134-142

  3. Uso de dalbavancina en pacientes en hemodiálisis con infecciones protésicas endovasculares por microorganismos multirresistente.

    Diálisis y trasplante: publicación oficial de la Sociedad Española de Diálisis y Trasplante, Vol. 41, Núm. 2, pp. 18-20